Cargando…
Inhibition of GSK 3β Activity Is Associated with Excessive EZH2 Expression and Enhanced Tumour Invasion in Nasopharyngeal Carcinoma
BACKGROUND: Enhancer of zeste homolog 2 (EZH2) has been shown to contribute to tumour development and/or progression. However, the signalling pathway underlying the regulation of EZH2 in nasopharyngeal carcinoma (NPC) remains unclear. Since EZH2 contains the putative Glycogen synthase kinase 3 beta...
Autores principales: | Ma, Renqiang, Wei, Yi, Huang, Xiaoming, Fu, Ran, Luo, Xi, Zhu, Xiaolin, Lei, Wenbin, Fang, Jugao, Li, Huabin, Wen, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715493/ https://www.ncbi.nlm.nih.gov/pubmed/23874688 http://dx.doi.org/10.1371/journal.pone.0068614 |
Ejemplares similares
-
Broncho-Vaxom Attenuates Allergic Airway Inflammation by Restoring GSK3β-Related T Regulatory Cell Insufficiency
por: Fu, Ran, et al.
Publicado: (2014) -
EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders
por: Yue, Dongyou, et al.
Publicado: (2021) -
UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway
por: Hu, Wei, et al.
Publicado: (2016) -
miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2
por: YU, LI, et al.
Publicado: (2013) -
The role of EZH2 in tumour progression
por: Chang, C-J, et al.
Publicado: (2012)